Throughout this week the eleventh edition of Biospain 2023 was held, an event that took place from 26 to 28 September at the Fira de Barcelona – Montjuïc. This international reference conference is organized by the Spanish Association of Biocompanies (AseBio) in collaboration with Biocat, the Ajuntament de Barcelona and the Generalitat de Catalunya.
During the three days of the congress, the biotechnology sector has been positioned as the driving force behind the new health model and a key element to achieve strategic autonomy for Spain and Europe in areas such as the economy, health, sustainable food and the green industrial transition.
Ahead Therapeutics team has been present at the event with Martí Dalmases (CEO) & Bruna Barneda Zahonero (Preclinical & clinical development director) participating in all the news of the sector.
It has been an event full of news and great professionals of the sector!